[Efficiency of lomefloxacine in combined treatment of patients with multiresistant pulmonary tuberculosis complicated with nonspecific bronchopulmonary infection].
Mishin
V Iu
VIu
Vasil'eva
I A
IA
Martynova
L P
LP
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D024841:Fluoroquinolones; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D008875:Middle Aged; D015363:Quinolones / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy*; D012293:Rifampin / Q000494:pharmacology; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000150:complications / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D024841:Fluoroquinolones; D015363:Quinolones; C053091:lomefloxacin; D007538:Isoniazid; D012293:Rifampin